VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333

Sort by:

Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Genital Herpes Drug pipeline report- 2020 is an annual R&D review of Genital Herpes pipeline candidates. The report presents the current status of all major Genital Herpes therapeutic compounds. Detai...

October 2019 70 pages

Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Gonorrhea Drug pipeline report- 2020 is an annual R&D review of Gonorrhea pipeline candidates. The report presents the current status of all major Gonorrhea therapeutic compounds. Detailed insights in...

October 2019 50 pages

Haemophilus influenzae Type B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Haemophilus influenzae Type B Infections Drug pipeline report- 2020 is an annual R&D review of Haemophilus influenzae Type B Infections pipeline candidates. The report presents the current status of a...

October 2019 60 pages

Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hand, Foot and Mouth Disease Drug pipeline report- 2020 is an annual R&D review of Hand, Foot and Mouth Disease pipeline candidates. The report presents the current status of all major Hand, Foot and...

October 2019 40 pages

Hepatitis A Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hepatitis A Drug pipeline report- 2020 is an annual R&D review of Hepatitis A pipeline candidates. The report presents the current status of all major Hepatitis A therapeutic compounds. Detailed insig...

October 2019 30 pages

Hepatitis D Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hepatitis D Drug pipeline report- 2020 is an annual R&D review of Hepatitis D pipeline candidates. The report presents the current status of all major Hepatitis D therapeutic compounds. Detailed insig...

October 2019 50 pages

Hepatitis E Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hepatitis E Drug pipeline report- 2020 is an annual R&D review of Hepatitis E pipeline candidates. The report presents the current status of all major Hepatitis E therapeutic compounds. Detailed insig...

October 2019 30 pages

Herpes Labialis (Oral Herpes) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Herpes Labialis (Oral Herpes) Drug pipeline report- 2020 is an annual R&D review of Herpes Labialis (Oral Herpes) pipeline candidates. The report presents the current status of all major Herpes Labial...

October 2019 50 pages

Herpes Zoster (Shingles) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Herpes Zoster (Shingles) Drug pipeline report- 2020 is an annual R&D review of Herpes Zoster (Shingles) pipeline candidates. The report presents the current status of all major Herpes Zoster (Shingles...

October 2019 50 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drug pipeline report- 2020 is an annual R&D review of Hospital Acquired Methicillin-Resistant Staphylococcus aureus (...

October 2019 40 pages

Hospital Acquired Pneumonia (HAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hospital Acquired Pneumonia (HAP) Drug pipeline report- 2020 is an annual R&D review of Hospital Acquired Pneumonia (HAP) pipeline candidates. The report presents the current status of all major Hospi...

October 2019 80 pages

Human Parainfluenza Virus Type 3 Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Human Parainfluenza Virus Type 3 Infections Drug pipeline report- 2020 is an annual R&D review of Human Parainfluenza Virus Type 3 Infections pipeline candidates. The report presents the current statu...

October 2019 40 pages

Impetigo Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Impetigo Drug pipeline report- 2020 is an annual R&D review of Impetigo pipeline candidates. The report presents the current status of all major Impetigo therapeutic compounds. Detailed insights into...

October 2019 30 pages

Influenza A Virus, H3N2 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Influenza A Virus, H3N2 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H3N2 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 120 pages

Influenza A Virus, H5N1 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Influenza A Virus, H5N1 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H5N1 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 130 pages

Influenza A Virus, H7N9 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Influenza A Virus, H7N9 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H7N9 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 60 pages

Influenzavirus B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Influenzavirus B Infections Drug pipeline report- 2020 is an annual R&D review of Influenzavirus B Infections pipeline candidates. The report presents the current status of all major Influenzavirus B...

October 2019 100 pages

Japanese Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Japanese Encephalitis Drug pipeline report- 2020 is an annual R&D review of Japanese Encephalitis pipeline candidates. The report presents the current status of all major Japanese Encephalitis therape...

October 2019 40 pages

Klebsiella pneumoniae Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Klebsiella pneumoniae Infections Drug pipeline report- 2020 is an annual R&D review of Klebsiella pneumoniae Infections pipeline candidates. The report presents the current status of all major Klebsie...

October 2019 100 pages

Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Lassa Fever (Lassa Hemorrhagic Fever) pipeline candidates. The report presents the current status of all maj...

October 2019 50 pages

Leishmaniasis (Kala-Azar) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Leishmaniasis (Kala-Azar) Drug pipeline report- 2020 is an annual R&D review of Leishmaniasis (Kala-Azar) pipeline candidates. The report presents the current status of all major Leishmaniasis (Kala-A...

October 2019 100 pages

Lyme Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Lyme Disease Drug pipeline report- 2020 is an annual R&D review of Lyme Disease pipeline candidates. The report presents the current status of all major Lyme Disease therapeutic compounds. Detailed in...

October 2019 50 pages

Lymphatic Filariasis (Elephantiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Lymphatic Filariasis (Elephantiasis) Drug pipeline report- 2020 is an annual R&D review of Lymphatic Filariasis (Elephantiasis) pipeline candidates. The report presents the current status of all major...

October 2019 30 pages

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline candidates. The report presents t...

October 2019 60 pages

Measles Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Measles Drug pipeline report- 2020 is an annual R&D review of Measles pipeline candidates. The report presents the current status of all major Measles therapeutic compounds. Detailed insights into Mea...

October 2019 40 pages

Meningitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Meningitis Drug pipeline report- 2020 is an annual R&D review of Meningitis pipeline candidates. The report presents the current status of all major Meningitis therapeutic compounds. Detailed insights...

October 2019 30 pages

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Drug pipeline report- 2020 is an annual R&D review of Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline candidate...

October 2019 40 pages

Middle East Respiratory Syndrome (MERS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Middle East Respiratory Syndrome (MERS) Drug pipeline report- 2020 is an annual R&D review of Middle East Respiratory Syndrome (MERS) pipeline candidates. The report presents the current status of all...

October 2019 70 pages

Mumps Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Mumps Drug pipeline report- 2020 is an annual R&D review of Mumps pipeline candidates. The report presents the current status of all major Mumps therapeutic compounds. Detailed insights into Mumps pip...

October 2019 40 pages

Neisseria meningitidis Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Neisseria meningitidis Infections Drug pipeline report- 2020 is an annual R&D review of Neisseria meningitidis Infections pipeline candidates. The report presents the current status of all major Neiss...

October 2019 70 pages

Osteomyelitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Osteomyelitis Drug pipeline report- 2020 is an annual R&D review of Osteomyelitis pipeline candidates. The report presents the current status of all major Osteomyelitis therapeutic compounds. Detailed...

October 2019 30 pages

Pertussis (Whooping Cough) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Pertussis (Whooping Cough) Drug pipeline report- 2020 is an annual R&D review of Pertussis (Whooping Cough) pipeline candidates. The report presents the current status of all major Pertussis (Whooping...

October 2019 70 pages

Poliomyelitis (Polio) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Poliomyelitis (Polio) Drug pipeline report- 2020 is an annual R&D review of Poliomyelitis (Polio) pipeline candidates. The report presents the current status of all major Poliomyelitis (Polio) therape...

October 2019 70 pages

Progressive Multifocal Leukoencephalopathy Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Progressive Multifocal Leukoencephalopathy Drug pipeline report- 2020 is an annual R&D review of Progressive Multifocal Leukoencephalopathy pipeline candidates. The report presents the current status...

October 2019 40 pages

Pseudomonas aeruginosa Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Pseudomonas aeruginosa Pneumonia Drug pipeline report- 2020 is an annual R&D review of Pseudomonas aeruginosa Pneumonia pipeline candidates. The report presents the current status of all major Pseudom...

October 2019 40 pages

Pyelonephritis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Pyelonephritis Drug pipeline report- 2020 is an annual R&D review of Pyelonephritis pipeline candidates. The report presents the current status of all major Pyelonephritis therapeutic compounds. Detai...

October 2019 60 pages

Q Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Q Fever Drug pipeline report- 2020 is an annual R&D review of Q Fever pipeline candidates. The report presents the current status of all major Q Fever therapeutic compounds. Detailed insights into Q F...

October 2019 20 pages

Rabies Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Rabies Drug pipeline report- 2020 is an annual R&D review of Rabies pipeline candidates. The report presents the current status of all major Rabies therapeutic compounds. Detailed insights into Rabies...

October 2019 60 pages

Rhinovirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Rhinovirus Infections Drug pipeline report- 2020 is an annual R&D review of Rhinovirus Infections pipeline candidates. The report presents the current status of all major Rhinovirus Infections therape...

October 2019 50 pages

Rotavirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Rotavirus Infections Drug pipeline report- 2020 is an annual R&D review of Rotavirus Infections pipeline candidates. The report presents the current status of all major Rotavirus Infections therapeuti...

October 2019 50 pages

Schistosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Schistosomiasis Drug pipeline report- 2020 is an annual R&D review of Schistosomiasis pipeline candidates. The report presents the current status of all major Schistosomiasis therapeutic compounds. De...

October 2019 40 pages

Severe Acute Respiratory Syndrome (SARS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Severe Acute Respiratory Syndrome (SARS) Drug pipeline report- 2020 is an annual R&D review of Severe Acute Respiratory Syndrome (SARS) pipeline candidates. The report presents the current status of a...

October 2019 70 pages

Smallpox Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Smallpox Drug pipeline report- 2020 is an annual R&D review of Smallpox pipeline candidates. The report presents the current status of all major Smallpox therapeutic compounds. Detailed insights into...

October 2019 50 pages

Streptococcus pyogenes Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Streptococcus pyogenes Infections Drug pipeline report- 2020 is an annual R&D review of Streptococcus pyogenes Infections pipeline candidates. The report presents the current status of all major Strep...

October 2019 50 pages

Tetanus Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Tetanus Drug pipeline report- 2020 is an annual R&D review of Tetanus pipeline candidates. The report presents the current status of all major Tetanus therapeutic compounds. Detailed insights into Tet...

October 2019 70 pages

Tinea pedis (Athlete Foot) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Tinea pedis (Athlete Foot) Drug pipeline report- 2020 is an annual R&D review of Tinea pedis (Athlete Foot) pipeline candidates. The report presents the current status of all major Tinea pedis (Athlet...

October 2019 40 pages

Toxoplasmosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Toxoplasmosis Drug pipeline report- 2020 is an annual R&D review of Toxoplasmosis pipeline candidates. The report presents the current status of all major Toxoplasmosis therapeutic compounds. Detailed...

October 2019 40 pages

Tularemia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Tularemia Drug pipeline report- 2020 is an annual R&D review of Tularemia pipeline candidates. The report presents the current status of all major Tularemia therapeutic compounds. Detailed insights in...

October 2019 40 pages

Typhoid Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Typhoid Fever Drug pipeline report- 2020 is an annual R&D review of Typhoid Fever pipeline candidates. The report presents the current status of all major Typhoid Fever therapeutic compounds. Detailed...

October 2019 50 pages

Vancomycin Resistant Enterococcus (VRE) faecium Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Vancomycin Resistant Enterococcus (VRE) faecium Infections Drug pipeline report- 2020 is an annual R&D review of Vancomycin Resistant Enterococcus (VRE) faecium Infections pipeline candidates. The rep...

October 2019 70 pages

Filters

Clear all

Publishers

VPAResearch

58,333

Price

—

Date

—

Pages

—

Offers